Navigation Links
Pharmacyclics Reports Results for Six and Three Months Ended December 31, 2012
Date:2/14/2013

ck is a process designed to facilitate the development, and expedite the review of drugs to treat serious diseases and fill an unmet medical need. The purpose is to get important new drugs to the patient earlier.

During the first half of 2013 the Company will be having discussions with regulatory authorities regarding future clinical development plans for ibrutinib's use in patients with DLBCL. The Company expects to be able to provide further updates in the third quarter of 2013.

Conference Call and further Corporate UpdatesThe Company will hold a conference call today at 4:30 p.m. EST. To participate in the conference call, please dial 1-877-407-0778 for domestic callers and 1-201-689-8565 for international callers. To access the live audio broadcast or the subsequent archived recording, log on to http://ir.pharmacyclics.com/events.cfm. The archived version of the webcast will be available for 30 days on the Investor Relations section of the company's Web site at http://www.pharmacyclics.com.

Use of Non-GAAP Financial MeasuresThis press release contains non-GAAP financial measures, including operating expenses and other expenses adjusted to exclude certain non-cash expenses. These measures are not in accordance with, or an alternative to generally accepted accounting principles, or GAAP, and may be different from non-GAAP financial measures used by other companies. The items included in GAAP presentations but excluded for purposes of determining non-GAAP financial measures for the periods presented in this press release are employee related non-cash expenses. The Company believes the presentation of non-GAAP financial measures provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations. When GAAP financial measures are viewed in conjunction w
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Pharmacyclics Reports Fiscal 2013 First Quarter Financial Results and Multiple PCI-32765 Presentations at the 54th American Society of Hematology Annual Meeting
2. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
4. Interleukin Genetics Reports Third Quarter 2011 Financial Results
5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
7. Pharmasset Reports Fiscal Year End 2011 Financial Results
8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
9. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
10. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
11. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... AudioNotch is the leading ... AudioNotch is pleased to announce a partnership with ... both British Columbia and Alberta, Destination Hearing is ... AudioNotch's tinnitus treatment program is now available at ... Hearing clinic, patients have the detection of their ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Envera announced ... Fermentation Manager. Mr. McErlean has an extensive background ... leadership positions throughout his career. , Mike ... very pleased to have Mike join our team”. “Mike’s ... large scale fermentation and downstream processing equipment”, ...
(Date:5/21/2013)... May 22, 2013 First patients ... of glycopyrronium bromide designed using Prosonix, particle engineering platform ... a portfolio of inhaled Respiratory Medicines by Design ... PSX1002 that will assess its effect on lung function ... patients with moderate to severe chronic obstructive pulmonary disease ...
(Date:5/21/2013)... May 21, 2013 Through science fairs, ... funds for lab equipment, 25 organizations will continue their ... of optics and photonics in daily life with the ... The organizations, located in 10 countries, are the first ... awarded by SPIE, the international society for optics ...
Breaking Biology Technology:AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Envera Appoints Michael McErlean Fermentation Manager 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3
... Wis. After Gov. Jim Doyle vetoed a bill ... for research purposes, the legislative director of Wisconsins Right to ... a science fiction movie. , ,We're not talking about stem ... . not for stem cells but for organs and body ...
... a safe assumption that all practicing lawyers have commercial websites. Or, ... "blawgs" as legal blogs are called - are another matter. Here ... raft of blawgs. , , Blawgs ,The gold ... brief list of other blawgs: , WisBlawg - From the ...
... - Gov. Jim Doyle announced Thursday his veto of ... cloning in Wisconsin. , ,The bill would outlaw not only ... or research cloning, in which an embryo is created with ... harvesting stem cells during the first several days of development. ...
Cached Biology Technology:Separating science fiction from reality in the human cloning debate 2Separating science fiction from reality in the human cloning debate 3'Blawg' use in law firms is on the rise 2'Blawg' use in law firms is on the rise 3'Blawg' use in law firms is on the rise 4Doyle vetoes cloning ban 2
(Date:5/22/2013)... 22, 2013 U.S. Forest Service scientists are part ... funding from the TKF Foundation, will examine how collaborative ... individuals recover from tragedy. , The TKF Foundation announced ... projects selected for grant funding. In addition to research ... in recovery and resiliency, the 3-year, $585,000 grant will ...
(Date:5/22/2013)... National Lung Screening Trial (NLST) investigators also conclude ... mortality with low-dose computed tomography (LDCT) versus chest ... primary paper is achievable at experienced screening centers ... more information to share with their patients about ... screening following today,s publication in the New ...
(Date:5/22/2013)... durability in fuel cell powered buses, including a ... between electrode degradation processes and bus membrane durability. ... electrode degradation stressors in the operating cycle of ... findings of the study, led by SFU graduate ... long-term study at Burnaby-based Ballard Power Systems and ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3Tests lead to doubling of fuel cell life 2
... December 3, 2008. The first 5-year forest inventory report for ... public: Oregon,s Forest Resources, 2001-2005: Five-Year Forest Inventory and Analysis ... report:, , Oregon,s forests span about 30 million acres; ... acres. , Forest land is being converted to other uses ...
... Scripps Institution of Oceanography at UC San Diego ... unprecedented details of vibrant sea life and ecosystems ... new species and marine animals previously never seen ... unexplored depths, have revealed disturbing declines in sea-life ...
... a corrective gene into mouse blood cells, scientists at ... disease pathology. In their studies, the researchers found that ... mice. Although the scientists caution that applying the gene ... that the new therapy will become an important treatment ...
Cached Biology News:Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 2Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 4Gene therapy corrects sickle cell disease in laboratory study 2Gene therapy corrects sickle cell disease in laboratory study 3
Zonula Adherens Sampler Kit 10 mu g each...
Tumor Suppressor Sampler Kit 10 mu g each...
Umbilical cord blood eosinophils, For immunohistochemistry (IHC)...
Human peripheral blood PBMCs, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Biology Products: